日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetic Determinants of Hematopoietic Toxicity Risk in Thai Pediatric Patients Undergoing 6-Mercaptopurine Treatment

泰国接受6-巯基嘌呤治疗的儿科患者造血毒性风险的遗传决定因素

Khaeso, Kanyarat; Chainansamit, Su-On; Kuwatjanakul, Pitchayanan; Komvilaisak, Patcharee; Nakkam, Nontaya; Suwannaying, Kunanya; Vannaprasaht, Suda; Dornsena, Areerat; Tassaneeyakul, Wichittra

An Updated Economic Evaluation of HLA-B*58:01 Genotype Testing in Gouty Patients for Preventing Severe Allopurinol Hypersensitivity in Thailand

泰国痛风患者HLA-B*58:01基因型检测预防严重别嘌醇过敏反应的最新经济评估

Dilokthornsakul, Piyameth; Louthrenoo, Worawit; Yadee, Jirawit; Siripaitoon, Boonjing; Jatuworapruk, Kanon; Vannaprasaht, Suda; Rerkpattanapipat, Ticha; Chungcharoenpanich, Apinya; Iamsumang, Wimolsiri; Upakdee, Nilawan; Dechanont, Supinya; Lawanaskol, Suppachai; Butthum, Bodin; Chevaisrakul, Parawee; Towiwat, Patapong

Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients.

泰国儿童急性淋巴细胞白血病患者中与 6-巯基嘌呤诱导的骨髓抑制相关的药物代谢酶的遗传多态性

Khaeso Kanyarat, Nakkam Nontaya, Komwilaisak Patcharee, Wongmast Piyathida, Chainansamit Su-On, Dornsena Areerat, Kanjanawart Sirimas, Vannaprasaht Suda, Tassaneeyakul Wichittra

SCN5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome

SCN5A基因多态性与布鲁加达综合征患者除颤器电击次数增加相关

Makarawate, Pattarapong; Chaosuwannakit, Narumol; Vannaprasaht, Suda; Sahasthas, Dujdao; Koo, Seok Hwee; Lee, Edmund Jon Deoon; Tassaneeyakul, Wichittra; Barajas-Martinez, Hector; Hu, Dan; Sawanyawisuth, Kittisak

The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients

非遗传因素和遗传因素对泰国患者稳定华法林剂量的影响

Wattanachai, Nitsupa; Kaewmoongkun, Sutthida; Pussadhamma, Burabha; Makarawate, Pattarapong; Wongvipaporn, Chaiyasith; Kiatchoosakun, Songsak; Vannaprasaht, Suda; Tassaneeyakul, Wichittra